» Articles » PMID: 29142484

Contemporary Management of Pulmonary Arteriovenous Malformations

Overview
Journal Int J Angiol
Date 2017 Nov 17
PMID 29142484
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary arteriovenous malformations (PAVMs) are atypical vascular structures involving a direct connection between the pulmonary arterial and venous circulations. While PAVMs are a relatively uncommon disorder, unmanaged cases are at risk for the development of serious complications including embolization and infection. Since their first description in 1897, PAVMs have been identified and treated in a variety of ways. Advancements in diagnostic methods and operative techniques have allowed for more effective treatment of the disease. Most recently, the use of vascular plug transcatheter embolization has been described as an effective therapeutic procedure in the management of PAVMs. In this report, we present our experience with nine cases of PAVMs treated at the University of Kentucky, including special consideration of an exemplary case that illustrates the typical course of treatment for the disease.

Citing Articles

A Meta-Analysis and Meta-Regression of Embolisation Outcomes of Pulmonary Arteriovenous Malformations.

Shahin Y, Vijayakumar C, Gill A, Lejawka A, Bennett S, Willis R Cardiovasc Intervent Radiol. 2024; 48(2):167-179.

PMID: 39557677 DOI: 10.1007/s00270-024-03907-6.


Robotic right lower lobectomy for a persistent large pulmonary arteriovenous malformation following repeated coil embolization.

Lengyel B, Watson J, Kim M, Lumsden A J Vasc Surg Cases Innov Tech. 2024; 10(6):101605.

PMID: 39314857 PMC: 11417312. DOI: 10.1016/j.jvscit.2024.101605.


Targeting Nanoparticles to Bioengineered Human Vascular Networks.

Cullion K, Petishnok L, Koo H, Harty B, Melero-Martin J, Kohane D Nano Lett. 2021; 21(15):6609-6616.

PMID: 34296614 PMC: 8719414. DOI: 10.1021/acs.nanolett.1c02027.


From 78% oxygen saturation to 95% in 60 minutes: Osler-Weber-Rendu syndrome endovascular treatment.

Maciej S, Sojka M, Pyra K, Jargiello T Postepy Kardiol Interwencyjnej. 2021; 16(3):354-355.

PMID: 33598006 PMC: 7863809. DOI: 10.5114/aic.2020.99277.


Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia.

Major T, Csobay-Novak C, Gindele R, Szabo Z, Bora L, Joni N J Int Med Res. 2019; 48(2):300060519860971.

PMID: 31510822 PMC: 7607172. DOI: 10.1177/0300060519860971.

References
1.
Choong C, Goodenberger D, Picus D, Meyers B . Surgical treatment of recurrent transient ischemic attacks and hemoptysis in a young man with multiple pulmonary arteriovenous malformations. J Thorac Cardiovasc Surg. 2005; 130(5):1456-8. DOI: 10.1016/j.jtcvs.2005.06.018. View

2.
Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K . Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology. 2000; 55(7):959-64. DOI: 10.1212/wnl.55.7.959. View

3.
Finnamore H, Le Couteur J, Hickson M, Busbridge M, Whelan K, Shovlin C . Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency. PLoS One. 2013; 8(10):e76516. PMC: 3797784. DOI: 10.1371/journal.pone.0076516. View

4.
SLOAN R, COOLEY R . Congenital pulmonary arteriovenous aneurysm. Am J Roentgenol Radium Ther Nucl Med. 1953; 70(2):183-210. View

5.
Nakayama M, Nawa T, Chonan T, Endo K, Morikawa S, Bando M . Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med. 2012; 51(13):1677-81. DOI: 10.2169/internalmedicine.51.7305. View